App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
CompletedOBSERVATIONAL
Enrollment
62
Participants
Timeline
Start Date
May 14, 2024
Primary Completion Date
October 20, 2024
Study Completion Date
October 20, 2024
Conditions
Cancer
Trial Locations (1)
55455
Masonic Cancer Center, Minneapolis
All Listed Sponsors
collaborator
Masonic Cancer Center, University of Minnesota
OTHER
lead
Daynamica, Inc.
INDUSTRY
NCT06322992 - App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3 | Biotech Hunter | Biotech Hunter